Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 75Sesión 2026

Qué cambió entre versiones

31 párrafos cambiaron+131 palabras agregadas−228 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

2026 SESSION

HOUSE SUBSTITUTE

INTRODUCED

26107743D26103193D

HOUSE BILL NO. 75

AMENDMENT IN THE NATURE OF A SUBSTITUTE

Offered January 14, 2026

Prefiled December 31, 2025

A BILL to amend the Code of Virginia by adding a section numbered 32.1-127.4, relating to medical care facilities; expanded access to medical cannabis for terminally ill patients.

—————

Patrons—Keys-Gamarra and Shin

—————

(ProposedReferred by the Houseto Committee on Health and Human Services

on ________________)

(Patrons Prior to Substitute—Delegates Keys-Gamarra, Shin [HB 486])

A BILL to amend the Code of Virginia by adding a section numbered 32.1-127.4, relating to medical care facilities; expanded access to medical cannabis for eligible patients.

—————

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding a section numbered 32.1-127.4 as follows:

§ 32.1-127.4. Expanded access to medical cannabis.

A . For the purpose of this section , " eligible p atient" means a person (i) who is 18 years of age or older and a resident of the Commonwealth, (ii) who has been diagnosed as having a terminal disease, and (iii) whose diagnosis as having a terminal disease has been confirmed by a consulting health care provider following an in-person examination and review of his medical records.

A . For the purpose of this section:

"Patient" means a person who has a terminal illness.

"Terminal illness" means a medical condition resulting in a prognosis of life of one year or less, if such medical condition follows its natural course.

B. A medical care facility shall establishpermit a policy to address circumstances under which a n eligible patient would be permitted to use medical cannabis in accordance with the requirements of the Medical Cannabis Program (§ 4.1-1600 et seq.) during an inpatient stay . SuchIn policyorder to facilitate such use, medical care facilities shall:

1. Prohibit smoking or vaping as methods to use medical cannabis ;

2. Include the use of medical cannabis within the eligible patient ' s medical records ;

3. Require a n eligible patient to provide a copy of the eligible patient ' s w ritten certification as described in § 4.1-1601 ;

4. Reasonably restrict the manner in which a n eligible patient stores and uses medical cannabis, including requiring the medical cannabis to be stored in a locked container, to ensure the safety of other patients, guests, and employees of the medicalhealth care facility, compliance with other state laws, and the safe operationoperations of the medicalhealth care facility ; and

5. Develop and disseminate written guidelines for the use of medical cannabis within the medical care facility pursuant to this chapter.

C. This section doe sdoes not apply to a n eligible patient receiving emergency medical services, as defined in § 32.1-111.1 , or to the emergency department of a hospit al while the eligible patient is receiving emergency medical services.

D. Medical care facilities permitting eligible patient use of medical cannabismarijuana shall comply with applicable drug and medication requirements. This sub section doe sdoes not require a medicalhealth care facility to provide a n eligible patient with a written certification to use medical cannabis in compliance with § 4.1-1601 or include medical cannabis in a n eligible patient ' s discharge plan.

E . If a federal regulatory agency, the United States Department of Justice (U . S . Department of Justice (DOJ), or the federal Centers for Medicare and Medicaid Services (CMS) takes one of the following actions, a medical care facility may suspend compliance with this section until the federal regulatory agency, U . S . DOJ, or CMS notifies the medical care facility that it may resume permitting the use of medical cannabis within the facility:

1. A federal regulatory agency or the U . S . DOJ initiates enforcement action against a medical care facility related to the facility ' s compliance with a state-regulated medical cannabismarijuana program ; or

2. A federal regulatory agency, the U . S . DOJ, or CMS issues a rule or otherwise provides notification to the medical care facility that expressly prohibits the use of medical cannabismarijuana in medical care facilities or otherwise prohibits compliance with a state-regulated medical cannabismarijuana program.

This sub section does not permit a medicalhealth care facility to prohibit eligible patient use of medicalmedicinal cannabis due solely to the fact that cannabis is a Schedule I II drug pursuant to the federal Controlled Substances Act or other federal constraints on the use of medicalmedicinal cannabis that were in existence prior to the enactment of this section .

F. RefusalCompliance to permit the use of medical cannabis pursuant towith this section shall not constitutebe a basiscondition tofor denyobtaining, issuanceretaining, or renewal of or to revoke or suspendrenewing a license as a medical care facility.

2. That the provisions of this act shall become effective on the date that cannabis is federally rescheduled from Schedule I to Schedule III under the federal Controlled Substances Act.

Volver al texto completo